Use of the IL‐6R antagonist tocilizumab in hospitalized COVID‐19 patients. (20th October 2020)

• Record Type: Journal Article
• Authors: Patel, K.; Gooley, T. A.; Bailey, N.; Bailey, M.; Hegerova, L.; Batchelder, A.; Holdread, H.; Dunleavy, V.; Downey, T.; Frisvold, J.; Megrath, S.; Pagarigan, K.; Szeto, J.; Rueda, J.; Islam, A.; Maree, C.; Nyatsatsang, S.; Bork, S. E.; Lipke, A.; O'Mahony, D. S.; Wagner, T.; Pulido, J.; Mignone, J.; Youssef, S.; Hartman, M.; Goldman, J. D.; Pagel, J. M.
• Is Part Of: Journal of internal medicine. Volume 289:Number 3(2021)
• Page Start: 430
• Page End: 433
• Publication Date: 2020-10-20
• Subjects: Internal medicine -- Periodicals; Medicine -- Periodicals; 616
• DOI: 10.1111/joim.13163
• Languages: English
• ISSNs: 0954-6820